Literature DB >> 8180208

Calmodulin-activated phosphorylation of dystrophin.

R Madhavan1, H W Jarrett.   

Abstract

Purified dystrophin glycoprotein complex (DGC) contains an endogenous protein kinase activity which phosphorylates dystrophin. Mg2+ (or Mn2+) and ATP are required for this phosphorylation. Ca(2+)-calmodulin increases the rate of phosphorylation of dystrophin 12-fold relative to the EGTA control, while other protein kinase activators, cAMP and cGMP, have no effect. Phosphorylation of other proteins in the DGC preparation was observed, with a 59-kDa protein also being phosphorylated in a calmodulin-dependent manner. These phosphorylations were all on serine residues. The DGC protein kinase activity also phosphorylates syntide-2, a peptide substrate for CaM kinase II, and antibodies raised against CaM kinase II cross-react with DGC blotted onto nitrocellulose. Further, purified, baculovirus-expressed CaM kinase II phosphorylates dystrophin and also phosphorylates at least one of the peptides of dystrophin which is phosphorylated by the DGC protein kinase activity, as shown by tryptic peptide maps. CaM kinase II also phosphorylates other proteins present in the DGC preparation that are phosphorylated by the endogenous protein kinase. Finally, dystrophin sequence 2618-3074, produced by recombinant techniques, is phosphorylated by both the DGC protein kinase and purified CaM kinase II. Since dystrophin and two other DGC components have also been shown to bind calmodulin, two important components of signal transduction--calmodulin binding and protein phosphorylation--operate in the DGC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180208     DOI: 10.1021/bi00185a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

Review 1.  Syntrophins entangled in cytoskeletal meshwork: Helping to hold it all together.

Authors:  Sahar S Bhat; Roshia Ali; Firdous A Khanday
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

2.  α-Syntrophin is required for the hepatocyte growth factor-induced migration of cultured myoblasts.

Authors:  Min Jeong Kim; Stanley C Froehner; Marvin E Adams; Hye Sun Kim
Journal:  Exp Cell Res       Date:  2011-10-06       Impact factor: 3.905

3.  Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

Authors:  Kristy Swiderski; Scott A Shaffer; Byron Gallis; Guy L Odom; Andrea L Arnett; J Scott Edgar; Dale M Baum; Annabel Chee; Timur Naim; Paul Gregorevic; Kate T Murphy; James Moody; David R Goodlett; Gordon S Lynch; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2014-07-31       Impact factor: 6.150

4.  Modulation by prednisolone of calcium handling in skeletal muscle cells.

Authors:  L Metzinger; A C Passaquin; W J Leijendekker; P Poindron; U T Rüegg
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  Phosphorylation of the carboxyl terminal region of dystrophin by mitogen-activated protein (MAP) kinase.

Authors:  C S Shemanko; J S Sanghera; R E Milner; S Pelech; M Michalak
Journal:  Mol Cell Biochem       Date:  1995-11-08       Impact factor: 3.396

6.  Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype.

Authors:  K Corrado; J A Rafael; P L Mills; N M Cole; J A Faulkner; K Wang; J S Chamberlain
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

7.  Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMDmdx rat model.

Authors:  Audrey Bourdon; Virginie François; Liwen Zhang; Aude Lafoux; Bodvael Fraysse; Gilles Toumaniantz; Thibaut Larcher; Tiphaine Girard; Mireille Ledevin; Cyrielle Lebreton; Agnès Hivonnait; Anna Creismeas; Marine Allais; Basile Marie; Justine Guguin; Véronique Blouin; Séverine Remy; Ignacio Anegon; Corinne Huchet; Alberto Malerba; Betty Kao; Anita Le Heron; Philippe Moullier; George Dickson; Linda Popplewell; Oumeya Adjali; Federica Montanaro; Caroline Le Guiner
Journal:  Gene Ther       Date:  2022-02-01       Impact factor: 4.184

Review 8.  Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy.

Authors:  Josè Manuel Pioner; Alessandra Fornaro; Raffaele Coppini; Nicole Ceschia; Leonardo Sacconi; Maria Alice Donati; Silvia Favilli; Corrado Poggesi; Iacopo Olivotto; Cecilia Ferrantini
Journal:  Front Physiol       Date:  2020-05-12       Impact factor: 4.566

9.  Syntrophin binds to an alternatively spliced exon of dystrophin.

Authors:  A H Ahn; L M Kunkel
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.